Tuesday 10 October 2023 imec
Opportunities for Belgium-Japan Cooperation in Digital MedTech
Thursday 28 September 2023 - 10:00 CET (17:00 JST)
With ageing populations, rising medical costs linked to the prevalence of chronic diseases and increasing societal demand, healthcare systems everywhere face unprecedented challenges in terms of quality of service and cost. By harnessing the power of AI, IoT and health data, the digital transformation of society can create a paradigm shift to address these challenges. The future of healthcare envisions a move from symptomatic treatment of acute diseases to predictive, preventative, personalised, participatory precision medicine and integrated care.
Digital MedTech covers a wide range of technologies including Mobile Health, Clinical Decision Support Systems (CDS), Digital Therapeutics (DTx). The MedTech ecosystem is highly innovative – according to the EPO, in 2022, 15,683 medical technology patent applications were filed making it the second biggest sector.
At this on-line event the BJA IPT Committee will build a bridge between Belgium and Japan to share initiatives and strategies to develop digital MedTech and address the opportunities for industrial and innovation cooperation in these fields.
09:55 CET (16:55 JST): Opening of the online event
10:00 CET (17:00 JST): Opening Note by Koh Ichi Masaki, Head of European Affairs, Japan Management Association JMA and BJA IPT Committee Co-Chair
10:05 CET (17:05 JST): "Overview of Some Key Legal Aspects in the Field of Digital Medical Technology: Personal and Non-Personal Data Protection, Artificial Intelligence, Cyber-Security and the Relationship between the EU and Japan (Europe-Japan Digital Partnership)” by Tanguy Van Overstraeten, Partner, Linklaters LLP, BJA Vice-President & BJA Executive Committee Chair
10:30 CET (17:30 JST): Current Status and Role of the ecosystem and innovation for the Digital Medical Healthcare
- Fabrizio Giannotta, Med Tech Business Coach, WSL Techno-entrepreneurs
- Christophe Reynaert, CEO, and Dieter Vansteenkiste, CEO, BeWell
- Christophe Coppens, Advisor, LifeTech Cluster
- Sander Poelert, Global R&D Director, Terumo Interventional Oncology
11:30 CET (18:30 JST): Q&A Session and Closing Note by Koh Ichi Masaki
11:45 CET (18:45 JST): Event Adjourns
Questions to the speakers are welcomed in advance. Kindly send them by email at firstname.lastname@example.org
Free of charge - registration mandatory
Zoom (the zoom link to attend the event will be sent one week in advance)
Please make your reservation latest by 21 September 2023.
This event is free of charge, but registration is mandatory.
The zoom link to attend the event will be sent one week in advance.